01 / CUSTOMER
Asset concept
Clinical need • indication • product concept • commercial opportunity
ODM development
From innovation to preclinical development.
How we develop
Our technology.
Your next product.
Maverick develops proprietary biomaterial technologies, then manufactures them for partners or licenses them for further development, all built on our materials and processing expertise.
Manufacture with Maverick
We manufacture the product for you using the same controlled source and processes established during development.
Processing & Manufacturing
License the technology
Acquire or license a preclinical technology and take it through development, regulatory approval and commercialisation.
Talk to our team
How we develop
From conceptto evidence.
Each technology moves through a defined development pathway, turning an early concept into a characterised, preclinical-ready product supported by the evidence needed for what comes next.
01 / Concept
02 / Feasibility and development
03 / Prototyping and characterisation
04 / Preclinical development
01 / Concept
A clinical need, a defined indication and a product concept with commercial potential.
02 / Feasibility and development
Material selection, formulation, process development and analytical strategy.
03 / Prototyping and characterisation
A characterised product made under controlled conditions, with defined specifications and traceability.
04 / Preclinical development
Safety, performance and technical evidence that prepares the technology for its next stage.
ODM Development journey
Preclinical out-licensing
pathway.
How an asset progresses from concept to preclinical validation, licensing and commercialisation.
02 / CDO / CDMO
Feasibility & development
Material selection • formulation • process development • analytical strategy
03 / CDO / CDMO
Preclinical-ready product
Characterised product • controlled manufacture • specifications • traceability
04 / PRECLINICAL VALIDATION
Preclinical validation
Safety
Biocompatibility • toxicology • GLP studies where required
Performance
Proof of concept • efficacy • functional performance
CMC / technical
Characterisation • stability • manufacturing controls
05 / CUSTOMER
Out-licensing ready
IP position • data room • development plan • regulatory pathway • commercial proposition
06 / LICENSING PARTNER
Due diligence
Technology • IP • preclinical evidence • CMC • regulatory pathway • scalability
07 / TRANSLATION
Clinical development & commercialisation
Partner advances the asset with CDO / CDMO support for tech transfer, scale-up and manufacturing.
What we bring
Built on the full
Maverick foundation.
Every ODM program draws on the same foundation: source control, scientific and processing expertise, certified quality systems and a path to commercial manufacture.
Source control
Australian and New Zealand origin materials, selected, controlled and traced from the source.
Certified quality systems
ISO 13485 and ISO 9001 certified, with controlled cleanroom manufacturing.
Processing and scientific expertise
Advanced processing backed by expertise across ECM biology, collagen biomaterials and 3D bioprinting.
A path to scale
The same controlled sources and processes can support development through commercial manufacture.
Partner with Maverick
A technology
to build on.
Tell us about the clinical need or product area you are exploring, and we’ll show you where Maverick’s technologies could fit.z
Frequently asked questions
